Clinical Trial Update: The Effect of Dihydroartemisinin in PCOS [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dihydroartemisinin for Polycystic Ovary Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Dihydroartemisinin (dihydroartemisinin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED